Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Nov;8(11):1549-58.
doi: 10.1586/erc.10.137.

Pulmonary hypertension in women

Meredith E Pugh  1 , Anna R Hemnes
Affiliations
Review

Pulmonary hypertension in women

Meredith E Pugh et al. Expert Rev Cardiovasc Ther. 2010 Nov.

Abstract

Female predominance in pulmonary arterial hypertension (PAH) has been known for several decades and recent interest in the effects of sex hormones on the development of disease has substantially increased our understanding of this epidemiologic observation. Basic science data suggest a beneficial effect of estrogens in the pulmonary vasculature both acutely and chronically, which seems to contradict the known predilection in women. Recent human and rodent data have suggested that altered levels of estrogen, differential signaling and altered metabolism of estrogens in PAH may underlie the gender difference in this disease. Studies of the effects of sex hormones on the right ventricle in animal and human disease will further aid in understanding gender differences in PAH. This article focuses on the effects of sex hormones on the pulmonary vasculature and right ventricle on both a basic science and translational level.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Sex hormone metabolism
2-MEOE2: 2-Methoxyestradiol; 2-OHE2: 2-Hydroxyestradiol; 4-MEOE2: 4-Methoxyestradiol; 4-OHE2: 4-Hydroxyestradiol; COMT: Catechol-O-methyltransferase; DHEA: Dehydroepiandrosterone.
See this image and copyright information in PMC

References

    1. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2009;54(1 Suppl.):S43–S54. - PubMed
    1. D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann. Intern. Med. 1991;115(5):343–349. - PubMed
    1. Lane KB, Machado RD, Pauciulo MW, et al. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat. Genet. 2000;26(1):81–84. - PubMed
    1. Loyd JE, Butler MG, Foroud TM, Conneally PM, Phillips JA, 3rd, Newman JH. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 1995;152(1):93–97. - PMC - PubMed
    1. Nichols WC, Koller DL, Slovis B, et al. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32. Nat. Genet. 1997;15(3):277–280. - PubMed

MeSH terms

LinkOut - more resources